Peptide PT‑141 (Bremelanotide): Libido and Sexual Arousal Support for Women and Men – Evidence, Timing, Safety and “Extra Benefits”
Context before we begin: PT-141 is an older name used by researchers to refer to Bremelanotide, a synthetic cyclic heptapeptide melanocortin receptor agonist. The first and currently only U.S. FDA-approved peptide using this active ingredient is the as-needed subcutaneously administered (under the skin via an injector pen) medication called Vyleesi (bremelanotide injection) for premenopausal women…